L’approche politique actuelle pour lutter contre la démence n’est pas viable socialement et économiquement, selon un nouveau rapport de l’OCDE. Les pays doivent agir immédiatement pour améliorer la vie des personnes atteintes de démence et celle de leurs soignants, donner la priorité à la recherche publique sur la démence, et encourager davantage l’investissement privé dans l’innovation pour la recherche sur la démence.
Dementia is increasing in prevalence, and to date has no cure or treatment. One element in improving this situation is using and sharing data more widely to increase the power of research. Further, moving beyond established medical data into big data offers the potential to tap into routinely collected data from both within and outside the health system.
An OECD policy perspective is now available which describes some of the major highlights from an OECD report on Nanotechnology and Tyres: Greening Industry and Transport.
English, PDF, 1,125kb
“Inclusive innovation” projects are initiatives that directly serve the welfare of lower-income and excluded groups. Inclusive innovations often modify existing technologies, products or services to better meet the needs of those groups.
This event, to be held on 10-12 February 2015 in New Delhi, will be a forum for high-level discussion and policy exchange among stakeholders concerned with the question of how innovation can best serve inclusive development.
OECD countries are developing strategies to improve the quality of life of those affected by dementia and to support long-term efforts for a disease-modifying therapy or cure. The OECD jointly hosted an international workshop in Toronto with the Ontario Brain Institute (OBI) and the Institute of Health Policy, Management and Evaluation (IHPME), University of Toronto on 14-15 September 2014. The aim of the workshop was to advance international discussion of the opportunities and challenges, as well as successful strategies, for sharing and linking the massive amounts of population-based health and health care data that are routinely collected (broad data) with detailed clinical and biological data (deep data) to create an international resource for research, planning, policy development, and performance improvement. The workshop brought together leading researchers and academics, industry and non-government experts to provide new insights into the opportunities and challenges in making “broad and deep” data a reality – from funding to data standards, to data sharing, to new analytics, to protecting privacy, and to engaging with stakeholders and the public. Government leadership and public-private partnership will be needed to create and sustain big data resources, including financing for data infrastructure and incentives for data sharing.
This project has reviewed how current measurement frameworks capture the broad range of innovation activities in firms, and in particular how design activities are reflected. It highlights which concepts, definitions and measurement approaches can be used to produce policy-relevant indicators on the role of design in innovation.
This working paper sums up the main findings of an OECD project aiming to provide an evidence basis for focusing efforts to improve the measurement of technological and non-technological forms of business innovation, with particular focus on the role of design. It reviews a broad range of novel design-related measures, indicating their advantages and limitations in terms of policy relevance and insights.
Micro-organisms play a fundamental role in the environment. Yet their role is the result of complex biogeochemical processes by consortia of micro-organisms and the function of individual species is not clear in many cases.
This publication provides an overview of the current situation and relevant developments in environmental microbiology, as well as its potential application, which covers: use of micro-organisms for agriculture, production purposes, bioremediation, and cleaning purpose; environmental applications of microbial symbionts of insects; and environmental risk/safety assessment of the deliberate release of engineered micro-organisms.
This event, to be held on 8-9 December 2014 in Paris, seeks to gather cross-country evidence on various aspects of business and innovation dynamics, including new business venture formation, the role of framework conditions, and resource allocation and inclusive growth.